Pacific biosciences of california stock.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a California-based biotech firm founded in 2004. It is ranked seventh on our list of 10 best biotech stocks to buy according to Cathie Wood.UBS Group upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Friday, Marketbeat.com reports. They currently have $10.00 price target on the biotechnology company’s stock, down from their previous price target of …Dec 4, 2023 · Pacific Biosciences of California last issued its quarterly earnings results on October 30th, 2023. The biotechnology company reported ($0.27) earnings per share for the quarter, beating analysts' consensus estimates of ($0.29) by $0.02. The business earned $55.70 million during the quarter, compared to analyst estimates of $48.76 million. Nov 30, 2023 · PacBio highly accurate long-read sequencing provides the most comprehensive view of genomes, transcriptomes, and epigenomes. Learn how SMRT sequencing powers genomic insights in humans, plants, animals and microbes. Track Pacific Biosciences of California Inc (PACB) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors
Pacific Biosciences of California Inc’s price is currently down 3.85% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.
(RTTNews) - Pacific Biosciences of California, Inc. (PACB) reported Loss for second quarter that decreased from the same period last year and beat the Street estimates. The company's bottom line ...
As of Tuesday, October 31, Pacific Biosciences of California Inc’s PACB share price has dipped by 13.08%, which has investors questioning if this is right time to buy. Premium Products ... Stock Superstars Report Get stock ideas inspired by the market's leading professionals; VMQ Stocks For the ...Get the latest PACB stock quote, news, history and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, insider transactions and related research of Pacific Biosciences of California, Inc. (PACB) on NasdaqGS. ٢٥/٠١/٢٠٢٣ ... Menlo Park, California-based PacBio sold approximately 11.2 million shares in a private investment in public equity (PIPE) financing in 2021 ...Pacific Biosciences of California Inc stock received a consensus recommendation rating of an Overweight, based on a mean score of 1.58. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 3 recommended PACB as a Hold, whereas 8 …٠٧/٠٨/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...
Apr 30, 2021 · PacBio announced record first-quarter revenue of $29 million, an 86% year-over-year increase and exactly what analysts expected. Meanwhile, the company recorded a net loss of $87.4 million -- or a ...
Jan 24, 2023 · Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it intends to offer and sell $150.0 million of shares of its common stock in an underwritten public offering.
Nov 15, 2023 · Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase. Jan 25, 2023 · 24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ... Nov 19, 2023 · Pacific Biosciences of California Inc. (PACB) Stock Performance and Future Outlook in the Health Technology Sector. On November 19, 2023, Pacific Biosciences of California Inc. (PACB) had an eventful day in the stock market. PACB started the day with an opening price of $7.82, slightly higher than its previous closing price of $7.59. MENLO PARK, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced the appointment of Susan G. Kim as Chief Financial Officer, effective as of September 28, …
Stocks of Pacific Biosciences of California Inc saw a sharp rise in short interest on Nov 14, 2023 jumping by 1.49 million shares to 39.23 million. Data from Yahoo Finance shows that the short interest on Oct 12, 2023 was 37.74 million shares. A jump of 3.8% in short interest reflects a negative sentiment towards the stock.٠٧/٠٨/٢٠٢٣ ... 9/13/2023 Pacific Biosciences CA sees its Relative Strength Rating reach the... Pacific Biosciences of California Stock Clears Key Benchmark, ...Pacific Biosciences of California Inc (NASDAQ:PACB)’s traded shares stood at 3.89 million during the last session, with the company’s beta value hitting 1.76. At the close of trading, the stock’s price was $8.36, to imply an increase of 0.97% or $0.08 in intraday trading.١٢/١٠/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...Pacific Biosciences of California Inc’s ( PACB) price is currently down 20.92% so far this month. During the month of February, Pacific Biosciences of California Inc’s stock price has reached a high of $12.35 and a low of $8.71. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.
Oct 30, 2023 · Oct. 30, 2023, 04:07 PM. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for third quarter that decreased from the same period last year and beat the Street estimates. The ... Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
On average, Wall Street analysts predict. that Pacific Biosciences Of California's share price could reach $10.57 by Nov 17, 2024. The average Pacific Biosciences Of California stock price prediction forecasts a potential upside of …Pacific Biosciences of California, Inc. ("PacBio") (NASDAQ: PACB) today announced that it has entered into a privately negotiated exchange agreement with a holder of PacBio's outstanding 1.50% ...Oct. 31. MT. Morgan Stanley Adjusts Price Target on Pacific Biosciences of California to $10 From $13, Maintains Equal-Weight Rating. Oct. 24. MT. Barclays Cuts Price Target on Pacific Biosciences of California $9 From $14, Maintains Equalweight Rating. Sep. 29. MT. Bernstein Starts Pacific Biosciences of California With Outperform Rating, $11 ...Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. The Company has developed Single Molecule, Real-Time (SMRT) technology, which …Pacific Biosciences of California Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Pacific Biosciences of California Inc’s trailing 12-month revenue is $169.5 million with a -182.3% profit margin. Year-over-year quarterly sales growth most recently was 72.4%.finance.yahoo.com - October 6 at 3:53 PM. Pacific Biosciences of California, Inc. (NASDAQ:PACB) Insider Sells $162,529.08 in Stock. marketbeat.com - September 29 at 8:19 PM. Bernstein Initiates Coverage of Pacific Biosciences of California (PACB) with Outperform Recommendation. msn.com - September 28 at 11:07 …Nov 17, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 17, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.40. Pacific Biosciences of California Inc is up 10.67% from its previous closing price of $7.59. Stock Quote. NASDAQ; PACB: Price; $8.88: Change; +0.4: Change(%); +4.72%: Volume; 4,099,397: 52 ... Pacific Biosciences of California, Inc. Third Quarter 2023 ...Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen. Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi...
٢٠/١١/٢٠٢٣ ... PACB has a roughly average overall score of 41 meaning the stock holds a better value than 41% of stocks at its current price.
١٣/٠٩/٢٠٢٣ ... Pacific Biosciences of California Stock Clears Key Benchmark, Hitting 80-Plus RS Rating ... The Relative Strength (RS) Rating for Pacific ...
STOCK INFORMATION IRS Notification Form 8937 Omniome Stock Quote Change Volume Today's Open Previous Close Today's High Today's Low 52 Week High 52 …Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Find the latest news headlines from Pacific Biosciences of California, Inc. Common Stock (PACB) at Nasdaq.com.MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.Stock analysis for Pacific Biosciences of California Inc (PACB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and …The five states that border the Pacific Ocean are California, Oregon, Washington, Alaska and Hawaii. The proximity of the states to the Pacific Ocean affects their climate. Along the coast, temperatures vary by as much as 19 degrees Fahrenh...Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD. Within the last quarter, Pacific Biosciences (NASDAQ:PACB) has observed the following analyst ratings: These 9 analysts have an average price target of $11.22 versus the current price of Pacific ...
The average twelve-month price prediction for Pacific Biosciences of California is $11.80 with a high price target of $17.00 and a low price target of $8.00. Learn more on PACB's analyst rating history. Do Wall Street analysts like Pacific Biosciences of California more than its competitors?Pacific Biosciences of California Inc’s price is currently up 8.37% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $10.00 and a low of $8.52. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.Aug 7, 2023 · Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago. Instagram:https://instagram. dividend tracker websitefsa administration companiesjpeq stocktradovate pulse Natural resources in California include waterways such as the San Joaquin Delta, the Pacific Ocean coastline, natural parks, plants and wildlife, and numerous habitats and ecosystems. Natural resources in California provide many economic an... dfa us small cap valueoxy dividends Pacific Biosciences of California Non-GAAP EPS of -$0.34 in-line, revenue of $35.5M beats by $0.34M SA News Wed, Aug. 03, 2022 As China looks to open up, here are the stocks with the most revenue ...Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025 [email protected] Email Alerts The Investor Relations website contains information … is moomoo real And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...Jan 20, 2022 · The stock price of Pacific Biosciences of California, a biotechnology company that develops gene sequencing systems, has seen a large fall of 38% over the last twenty-one trading days, while it is ... Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 11:18PM. Pacific Biosciences of California, Inc. Announces Pricing of Upsized Public Offering of Common Stock.